Sugi Predict

Sugi Predict / Compounds / SCHEMBL4598633

SCHEMBL4598633

SCHEMBL4598633

Nc1ccc(C(=O)CBr)cn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRP O00591 2/20 0.60
▸ GABRD O14764 2/20 0.60
▸ GABRA1 P14867 2/20 0.60
▸ GABRB1 P18505 2/20 0.60
▸ GABRG2 P18507 2/20 0.60
▸ GABRB3 P28472 2/20 0.60
▸ GABRA5 P31644 2/20 0.60
▸ GABRA3 P34903 2/20 0.60
▸ GABRA2 P47869 2/20 0.60
▸ GABRB2 P47870 2/20 0.60
▸ GABRA4 P48169 2/20 0.60
▸ GABRE P78334 2/20 0.60
▸ GABRA6 Q16445 2/20 0.60
▸ GABRG1 Q8N1C3 2/20 0.60
▸ GABRG3 Q99928 2/20 0.60
▸ GABRQ Q9UN88 2/20 0.60
▸ NNMT P40261 1/20 0.60
▸ SMN1; SMN2 Q16637 1/20 0.60
▸ HDAC1 Q13547 1/20 0.55
▸ HDAC6 Q9UBN7 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30213417 1.00 GABRP (0.60) GABRPGABRDGABRA1GABRB1GABRG2
Bromide SCHEMBL16753654 0.98 GABRP (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL4598981 0.81 GABRP (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL29505906 0.81 GABRP (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL10031594 0.81 GABRP (0.60) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL934394 0.78 GSK3B (0.55) GSK3BPTPN1
SCHEMBL16601153 0.78 PTPN1 (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL13838594 0.78 SMN1; SMN2 (0.56) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31438567 0.78 KMT2A (0.46) NNMTSMN1; SMN2GSK3BPTPN1
SCHEMBL4598630 0.78 KMT2A (0.46) NNMTSMN1; SMN2GSK3BPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151517-A1 THIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING DISORDERS ASSOCIATED WITH MISSFOLDING OF ALPHA-SYNUCLEIN PROTEIN WAVEBREAK THERAPEUTICS LIMITED (US) 2025-07-17 — — WO disclosed
US-20230167078-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AKTIENGESELLSCHAFT (DE) 2023-06-01 — — US disclosed
US-20230139936-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION BAYER AKTIENGESELLSCHAFT (DE) 2023-05-04 — — US disclosed
CN-115697980-A Substituted aminothiazoles as DGKZETA inhibitors for immune activation 拜耳公司 2023-02-03 — — CN disclosed
CN-112028877-B Alkoxy pyridone compound and preparation method and application thereof 江西济民可信集团有限公司 2021-11-26 — — CN disclosed
CN-112028877-A Alkoxy pyridone compound and preparation method and application thereof 江西济民可信集团有限公司 2020-12-04 — — CN disclosed
EP-3134408-B1 FACTOR XIa INHIBITORS MERCK SHARP & DOHME (US) 2020-08-12 — — EP disclosed
EP-2870156-B1 PYRIMIDINONE DERIVATIVES AS ANTIMALARIAL AGENTS SANOFI SA (FR) 2020-06-17 — — EP disclosed
EP-3283464-B1 FACTOR XIA INHIBITORS MERCK SHARP & DOHME (US) 2019-10-23 — — EP disclosed
EP-3283464-B1 FACTOR XIA INHIBITORS MERCK SHARP & DOHME (US) 2019-10-23 — — EP disclosed
US-20150183804-A1 Pyrimidinone Derivatives as Antimalarial Agents SANOFI (FR) 2015-07-02 — — US disclosed
US-7803823-B2 2-amino-4,5-trisubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA NV (BE) 2010-09-28 — — US disclosed
US-7803823-B2 2-amino-4,5-trisubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA NV (BE) 2010-09-28 — — US disclosed
EP-1910342-A1 MULTICYCLIC SULFONAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE Kalypsys, Inc. (US) 2008-04-16 — — EP disclosed
US-20070203189-A1 2-Amino-4,5-Trisubstituted Thiazolyl Derivatives LOVE CHRISTOPHER J 2007-08-30 — — US disclosed
US-20070203189-A1 2-Amino-4,5-Trisubstituted Thiazolyl Derivatives LOVE CHRISTOPHER J 2007-08-30 — — US disclosed
US-7232838-B2 2-amino-4,5-trisubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2007-06-19 — — US disclosed
US-7232838-B2 2-amino-4,5-trisubstituted thiazolyl derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2007-06-19 — — US disclosed
WO-2007016354-A1 MULTICYCLIC SULFONAMIDE COMPOUNDS AS INHIBITORS OF HISTONE DEACETYLASE FOR THE TREATMENT OF DISEASE KALYPSYS, INC. (US) 2007-02-08 — — WO disclosed
US-20070027184-A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease KALYPSYS, INC. 2007-02-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139936-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION DGKZ, DGKA, DGKG GABRP 2695/4885GABRD 1882/4885GABRA1 2836/4885
US-20230167078-A1 SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION DGKZ, DGKA, DGKG GABRP 2695/4885GABRD 1882/4885GABRA1 2836/4885
US-20150183804-A1 Pyrimidinone Derivatives as Antimalarial Agents DHFR, PRMT1, PRMT7 GABRP 3125/4885GABRD 3846/4885GABRA1 3282/4885
US-20070027184-A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease HDAC6, HDAC5, HDAC7 GABRP 4136/4885GABRD 4463/4885GABRA1 3973/4885
US-20070203189-A1 2-Amino-4,5-Trisubstituted Thiazolyl Derivatives IFNG, IL15, IL5 GABRP 1343/4885GABRD 2279/4885GABRA1 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.